TCL Archive Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday July 6, 2012
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: Delores Esparza President Elect Of ONS; Brown Demands Jako Retract “Insulting Remarks” May 13, 1988